| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |